Extracellular signal-regulated kinase/mitogen-activated protein kinases block internalization of δ-opioid receptors

被引:25
作者
Eisinger, DA [1 ]
Schulz, R [1 ]
机构
[1] Univ Munich, Inst Pharmacol Toxicol & Pharm, D-80539 Munich, Germany
关键词
D O I
10.1124/jpet.103.061788
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Translocation of G protein-coupled receptors (GPCRs) from the cell membrane to cytosol depends on the kind of ligand activating the receptor. This principle is clearly demonstrated for opioid receptors, because diverse opiate agonists rapidly induce receptor internalization, whereas morphine almost fails. We report here the impact of mitogen-activated protein (MAP) kinase isoforms extracellular signal-regulated kinase (ERK)1/2 on the internalization of delta-opioid receptors (DORs) expressed in human embryonic kidney (HEK)293 cells. Receptor activation by etorphine turned out to transiently phosphorylate ERK/MAP kinases and bring about DOR internalization within 20 min. In contrast, prolonged exposure of HEK293 cells to morphine excited persistent phosphorylation of ERK/MAP kinases, and those cells failed to internalize the opioid receptor. When ERK/MAP kinase phosphorylation was blocked by 2'-Amino-3'-methoxyflavone (PD98059), morphine gained the ability to strongly induce DOR endocytosis. The importance of activated MAP kinases for DOR internalization is further demonstrated by glutamate and paclitaxel because these substances induce phosphorylation of ERK1/2 and concomitantly prevent DOR sequestration by etorphine. In addition, receptor internalization by morphine was facilitated by inhibition of protein kinase C and opioid-mediated transactivation of epidermal growth factor receptor (EGFR), both activating ERK/MAP kinases by opioids. The mechanism affording DOR internalization by PD98059 may relate to arrestin, which uncouples GPCRs and thus triggers receptor internalization. Arrestin considerably translocates toward the cell membrane upon DOR activation by morphine in presence of the MAP kinase blocker, but it fails in the absence of PD98059. We conclude that ERK/MAP kinase activity prevents opioid receptor desensitization and sequestration by blocking arrestin 2 interaction with activated DORs.
引用
收藏
页码:776 / 785
页数:10
相关论文
共 46 条
[1]   MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway [J].
Ai, WD ;
Gong, JH ;
Yu, L .
FEBS LETTERS, 1999, 456 (01) :196-200
[2]   Enhanced stimulatory adenylyl cyclase signaling during opioid dependence is associated with a reduction in palmitoylated Gsα [J].
Ammer, H ;
Schulz, R .
MOLECULAR PHARMACOLOGY, 1997, 52 (06) :993-999
[3]   Opioid tolerance/dependence in neuroblastoma x glioma (NG108-15) hybrid cells is associated with a reduction in spontaneous stimulatory receptor activity [J].
Ammer, H ;
Schulz, R .
FEBS LETTERS, 2000, 485 (2-3) :157-162
[4]   μ-opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation [J].
Belcheva, MM ;
Szùcs, M ;
Wang, DX ;
Sadee, W ;
Coscia, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (36) :33847-33853
[5]   Activation of the mitogen-activated protein kinase pathway by a Gq/11-coupled muscarinic receptor is independent of receptor internalization [J].
Budd, DC ;
Rae, A ;
Tobin, AB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12355-12360
[6]   G-protein coupled receptor kinases as modulators of G-protein signalling [J].
Bünemann, M ;
Hosey, MM .
JOURNAL OF PHYSIOLOGY-LONDON, 1999, 517 (01) :5-23
[7]   Signal characteristics of G protein-transactivated EGF receptor [J].
Daub, H ;
Wallasch, C ;
Lankenau, A ;
Herrlich, A ;
Ullrich, A .
EMBO JOURNAL, 1997, 16 (23) :7032-7044
[8]   β-Arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2 [J].
DeFea, KA ;
Zalevsky, J ;
Thoma, MS ;
Déry, O ;
Mullins, RD ;
Bunnett, NW .
JOURNAL OF CELL BIOLOGY, 2000, 148 (06) :1267-1281
[9]   Phosphorylation of dynamin by ERK2 inhibits the dynamin-microtubule interaction [J].
Earnest, S ;
Khokhlatchev, A ;
Albanesi, JP ;
Barylko, B .
FEBS LETTERS, 1996, 396 (01) :62-66
[10]  
Eisinger DA, 2002, J NEUROSCI, V22, P10192